- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 19, 2022
Data Byte
The evolving geographic atrophy pipeline
Roche drops galegenimab and NGM data disappoint, as regulatory milestones approach for Apellis, Iveric
BioCentury | Nov 2, 2018
Finance
Bye-bye, build-to-buy
Why Versant is moving away from the build-to-buy model
Items per page:
1 - 2 of 2